a2 Milk receives approval to supply infant formula to USA

After a long application process, which began in May 2022 when the US was first experiencing shortages of infant milk formula (IMF), The a2 Milk Company has now received approval from the US Food and Drug Administration (FDA) to import, sell and distribute its a2 Platinum IMF product (Stages 1 and 2) from New Zealand into the US through to 6 January 2023.

The a2 Milk Company said in a market statement that its a2 Platinum product meets the FDA’s food safety and nutritional requirements so will be supplied to the US with the same formulation, but with different scoops, mixing instructions and labelling requirements to meet the FDA’s other requirements.

The product is not currently available in its inventory so will need to be manufactured as soon as possible. The supply capacity through Synlait Milk Limited is expected to be around 9 million cans (equivalent to 211 million 8 oz bottles) over a nine-month period, but this will be subject to consumer demand.

The a2 Milk Company’s Managing Director and CEO, David Bortolussi, said: “We are pleased to be able to assist parents and caregivers in the US by providing access to significant volumes of high-quality a2 Platinum infant and toddler milk formula manufactured in New Zealand during this challenging period.”

Image credit: iStock.com/Pilin_Petunyia